Antibody Tests

German biotech company CureVac to launch human trials for an experimental Coronavirus vaccine

The WHO lists 11 experimental coronavirus vaccines is currently being tested on humans, according to a table posted on its website.

FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits

In a separate announcement, the FDA has warned doctors against prescribing the HCQ in combination with remdesivir, the other drug shown to help COVID-19 patients.

Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19

HCQ has demonstrated in-vitro activity against SARS-CoV-2 and shown to be clinically beneficial in several small single-centre studies with significant limitations.

ICMR denies claims that it published a study saying India's coronavirus cases could peak by mid-November

The news reports attributing this study to ICMR are misleading. This refers to a non peer reviewed modelling, not carried out by ICMR and does not reflect the official position of ICMR, said the agency

WHO takes back statement saying asymptomatic patients spreading COVID-19 is rare, says they can cause 40 percent of transmissions

Maria van Kerkhove said, “Some estimates of around 40 percent of transmission may be due to asymptomatic (cases), but those are from models."

Ridiculous: Beijing dismisses Harvard study that suggests COVID-19 was already spreading in China, in August

The research uses satellite images of hospital parking lots in Wuhan and data for symptom-related queries on search engines for things like “cough” and “diarrhoea”.

Gilead's Remdesivir prevented lung disease in macaque monkeys infected with coronavirus: Study

The antiviral drug, Remdesivir is the first drug shown to be effective against COVID-19 in human trials.

China defends its Coronavirus efforts in an 84 page report, says they 'wasted no time' in sharing information

National Health Commission Chairman Ma Xiaowei said they "made an important contribution to the prevention and control of the epidemic around the world.”

Authors retract Lancet study that claimed higher death risk for COVID-19 patients treated with hydroxychloroquine

An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by US President Donald Trump.

WHO will resume its trial of hydroxychloroquine after studies claiming increased death rates are called into question

WHO’s chief scientist said “We owe it to patients to have a definitive answer on whether or not a drug works."